South African tycoon Gus Attridge rakes in $6.2 million from Aspen shares
This follows a $12 million gain recorded between April 23 and May 3, when his stake rose from R4.07 billion ($219.65 million) to R4.29 billion ($231.65 million).
Aspen Pharmacare
South African tycoon Gus Attridge gains nearly $12 million from Aspen shares
Attridge, Aspen’s group chief advisor, and a JSE heavyweight, holds a 4.3-percent stake in the pharmaceutical company, amounting to 19,033,829 ordinary shares.
South African billionaire Stephen Saad’s Aspen to boost global supply of obesity medication
Aspen, Africa’s largest drugmaker, is actively exploring ways to ramp up the availability of these in-demand treatments worldwide.
South African tycoon Gus Attridge gains $7.95 million from Aspen shares
The latest bump in his fortune comes on the heels of previous gains between Feb. 12 and March 24, when his stake in Aspen grew by R447.12 million ($25.12 million).
South African billionaire Stephen Saad gains $21.1 million as Aspen shares soar
This rise in Saad’s stake underscores his pivotal role in South Africa’s business landscape, placing him among the top investors on the JSE.
South African billionaire Stephen Saad leads Aspen to record $1.1-billion revenue
Aspen anticipates a robust second half of 2024, supported by the launch of sterile manufacturing contracts and continued growth in its active pharmaceutical ingredients (API) business.
South African tycoon Gus Attridge’s stake in Africa’s biggest pharma company hits $215 million
Attridge’s recent financial triumph is attributed to the recent surge in Aspen Pharmacare’s shares on the Johannesburg Stock Exchange (JSE).
South African billionaire Stephen Saad gains $49 million as Aspen shares soar
This increase cements Saad’s position in the South African business scene, placing him among the leading investors on the JSE.
South African tycoon Stephen Saad’s investment in Aspen surpasses $620 million
According to data compiled by Billionaires.Africa, the market value of Saad’s stake in Aspen has increased by $52.4 million to $623.6 million.
South African tycoon Gus Attridge suffers $8-million loss from Aspen shares
Attridge, Aspen’s group chief advisor who ranks as one of South Africa’s richest businessmen, owns a 4.26-percent stake in the pharmaceutical holding company.
South African tycoon Gus Attridge gains nearly $8 million in 16 days
Attridge, Aspen’s group chief advisor who ranks as one of JSE’s richest investors, owns a 4.26-percent stake in the pharma group.
South African tycoon Gus Attridge rakes in $19 million from Aspen shares
The upswing comes on the heels of a setback that led to Attridge recording a loss of $11.96 million between Oct. 2 and Oct. 26.
5 companies owned by South African businessman Gus Attridge
At the helm of Aspen Pharmacare, Attridge has made significant contributions to Africa’s healthcare sector.
5 companies owned by South African billionaire Stephen Saad
Beyond Aspen Pharmacare, Saad’s influence extends to a diverse array of companies, each representing a facet of his entrepreneurial prowess.
South African businessman Gus Attridge earns $1.3-million salary from Aspen
Apart from his executive and governance roles in Aspen Pharmacare, Attridge owns a notable 4.28-percent stake in Aspen.
South African businessman Gus Attridge loses $11.96 million in 24 days
Attridge, Aspen’s group chief advisor, who ranks as one of South Africa’s richest businessmen, owns a 4.26-percent stake in the pharmaceutical holding company.